These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8848337)

  • 1. Virus-induced immunosuppression is linked to rapidly fatal disease in infant rhesus macaques infected with simian immunodeficiency virus.
    Otsyula MG; Miller CJ; Marthas ML; Van Rompay KK; Collins JR; Pedersen NC; McChesney MB
    Pediatr Res; 1996 Apr; 39(4 Pt 1):630-5. PubMed ID: 8848337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques.
    Marthas ML; van Rompay KK; Otsyula M; Miller CJ; Canfield DR; Pedersen NC; McChesney MB
    J Virol; 1995 Jul; 69(7):4198-205. PubMed ID: 7769679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.
    Hirsch VM; Santra S; Goldstein S; Plishka R; Buckler-White A; Seth A; Ourmanov I; Brown CR; Engle R; Montefiori D; Glowczwskie J; Kunstman K; Wolinsky S; Letvin NL
    J Virol; 2004 Jan; 78(1):275-84. PubMed ID: 14671109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.
    Kaur A; Daniel MD; Hempel D; Lee-Parritz D; Hirsch MS; Johnson RP
    J Virol; 1996 Nov; 70(11):7725-33. PubMed ID: 8892893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques.
    Pahar B; Kenway-Lynch CS; Marx P; Srivastav SK; LaBranche C; Montefiori DC; Das A
    Virol J; 2016 Dec; 13(1):200. PubMed ID: 27903274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
    Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
    Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.
    Zhou D; Shen Y; Chalifoux L; Lee-Parritz D; Simon M; Sehgal PK; Zheng L; Halloran M; Chen ZW
    J Immunol; 1999 Feb; 162(4):2204-16. PubMed ID: 9973496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.
    Amos JD; Himes JE; Armand L; Gurley TC; Martinez DR; Colvin L; Beck K; Overman RG; Liao HX; Moody MA; Permar SR
    J Virol; 2015 Sep; 89(18):9485-98. PubMed ID: 26157116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile.
    Haigwood NL; Watson A; Sutton WF; McClure J; Lewis A; Ranchalis J; Travis B; Voss G; Letvin NL; Hu SL; Hirsch VM; Johnson PR
    Immunol Lett; 1996 Jun; 51(1-2):107-14. PubMed ID: 8811353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.
    Ansari AA; Mayne AE; Sundstrom JB; Bostik P; Grimm B; Altman JD; Villinger F
    J Virol; 2002 Feb; 76(4):1731-43. PubMed ID: 11799168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
    Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
    J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.
    Smith MO; Heyes MP; Lackner AA
    Lab Invest; 1995 May; 72(5):547-58. PubMed ID: 7745949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.
    Nacsa J; Radaelli A; Edghill-Smith Y; Venzon D; Tsai WP; Morghen Cde G; Panicali D; Tartaglia J; Franchini G
    Vaccine; 2004 Jan; 22(5-6):597-606. PubMed ID: 14741150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
    Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
    J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SIV env-specific CTL in the jejunal mucosa in vaginally exposed, seronegative rhesus macaques (Macaca mulatta).
    Wilson LA; Murphey-Corb M; Martin LN; Harrison RM; Ratterree MS; Bohm RP
    J Med Primatol; 2000 Aug; 29(3-4):173-81. PubMed ID: 11085580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques.
    von Herrath M; Oldstone MB; Fox HS
    J Immunol; 1995 May; 154(10):5582-9. PubMed ID: 7730657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251.
    Otsyula MG; Miller CJ; Tarantal AF; Marthas ML; Greene TP; Collins JR; van Rompay KK; McChesney MB
    Virology; 1996 Aug; 222(1):275-8. PubMed ID: 8806509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.